A study of the stability of solid dispersions of albendazole obtained by mechanochemical solid-phase synthesis

I n t r o d u c t i o n . Pharmacological treatment of opisthorchiasis remains the relevant challenge due to the limited choice of drugs against opisthorchiasis and their unsatisfactory biopharmaceutical properties. The use of the mechano-chemical method for obtaining solid dispersions (SDs) of albendazole (ALB) with excipients allows to increase its water-solubility and decrease toxicity. Investigation of the stability of SDs of ALB during long-term storage is a relevant objective of the further development of SDs of ALB-based dosage forms.

A i m . A study of the stability of SDs of ALB obtained by mechanochemical solid-phase synthesis.

M a t e r i a l s a n d m e t h o d s . The objects of the study were SDs of ALB with arabinogalactan (AG) and licorice extract (LE) as complexing agents in various mass ratios and at different machining duration. The stability of SDs of ALB was studied by the method of accelerated ageing at 40°C for 6 months. Stability control was carried out at 3 time points (0, 3 and 6 months, respectively) based on the description parameter and the ALB content that was measured using high-performance liquid chromatography.

R e s u l t s . The qualitative and quantitative parameters of the stability of SDs of ALB during storage were studied. The content of the main active substance at the end point for all studied samples is not less than 97% relative to the parent composition. Based on the van’t Hoff ’s rule, the concordance coefficient, the expected shelf life for SDs of ALB and the storage temperature allowing to ensure the estimated shelf life were calculated.

C o n c l u s i o n . SDs of ALB with AG and SDs of ALB with LE obtained by mechanochemical solid-phase synthesis are stable for 182 days of experimental storage, which corresponds to 728 days under natural conditions. The data obtained indicate high stability of the studied SDs of ALB and can be used in further development of dosage forms based on them.

1. Bibik O.I. Opisthorchosis is a topical health problem (problem review and analysis). Russian Journal of Parasitology. 2020;14(4):38-49. (In Russ.)

2. Plotnikova E.Yu., Baranova E.N. Opisthorchiasis: exacerbations and problems of treatment. Gastroenterology of St. Petersburg. 2018;(3):14-18. (In Russ.)

3. Chistyachenko Yu.S., Dushkin A.V., Hvostov M.V. et al. Perspective agent based on albendazole against O. felineus. Theory and Practice of Parasitic Disease Control. 2014;15:339-342. (In Russ.)

4. Dushkin A.V., Meteleva E.S., Tolstikova T.G. et al. Supramolecular systems for the delivery of the molecules of medicinal substances based on water-soluble plant metabolites. Physicochemical, pharmacological properties and the features of mechanochemical preparation. Chemistry for Sustainable Development. 2019; 27(3):233-244. DOI: 10.15372/KhUR2019129. (In Russ.)

5. Khalikov S.S., Evseenko V.I., Varlamova A.I. et al. Preparation of complex antihelminth drugs by methods of mechanochemistry. International Journal of Applied and Fundamental Research. 2023;2:44-52. DOI: 10.17513/mjpfi.13512. (In Russ.)

6. Khalikov S., Khalikov M., Meteleva E. et al. Mechanochemical modification of the properties of antihelminthic preparations. Chemistry for Sustainable Development. 2011;19(6):699-703. (In Russ.)

7. Dushkin A.V., Tolstikova T.G., Khvostov M.V., Tolstikov G.A. Complexes of polysaccharides and glycyrrhizic acid with drug molecules. Mechanochemical synthesis and pharmacological activity. In Dr. D.N. Karunaratnе (ed.) The Complex World of Polysacchаridеs. 2012. Р. 573–602.

8. Dushkin A.V., Meteleva E., Tolstikova T.G. et al. Combination of pharmacons with glycyrrhizinic acid – a path for development of improved efficiency drugs. Chemistry for Sustainable Development. 2010;18(4):517-525. (In Russ.)

9. Selyutina O.Yu., Polyakov N.E. Glycyrrhizic acid as a multifunctional drug carrier – From physicochemical properties to biomedical applications: A modern insight on the ancient drug// Int. J. Pharm. 2019;559:271-279. DOI: 10.1016/j.ijpharm.2019.01.047.

10. Khalikov S., Dushkin A.V., Chistjachenko J.S. Antiparasitic agent based on albendazole and method of its use for treatment of helminthoses of mammals. Patent of the RF No. RU 2546535. Publ. 10.04.2015. URL: https://yandex.ru/patents/doc/RU2546535C1_20150410 (accessed 06.03.2025).

11. Dushkin A.V., Meteleva E.S., Lyahov N.Z. et al. Albendazole-based composition with anti-opisthor-chosis pharmacological activity. Patent of the RF No. RU2545797. Publ. 10.04.2015. URL: https://yandex.ru/patents/doc/RU2545797C1_20150410 (accessed 06.03.2025).

12. Sakaeva I.V., Bunyatyan N.D., Kovaleva E.L. et al. Basic approaches to drug stability studies: domestic and international experience. Bulletin of the scientific centre for expert evaluation of medicinal products. Regulatory research and medicine evaluation. 2013;3:8-11. (In Russ.)

13. Interim guidance for detection of shelf life of medicines based on an accelerated stability study at elevated temperatures URL: https://docs.cntd.ru/document/1200114789 (accessed 06.03.2025).